Assenagon Asset Management S.A. Charles River Laboratories International, Inc. Transaction History

Assenagon Asset Management S.A.

  • $65.1 Billion
  • Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 32,289 shares of CRL stock, worth $5.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,289
Previous 581,505 94.45%
Holding current value
$5.78 Million
Previous $88.2 Million 94.28%
% of portfolio
0.01%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025
SELL
$145.57 - $178.99 $79.9 Million - $98.3 Million
-549,216 Reduced 94.45%
32,289 $5.05 Million
Q2 2025

Jul 11, 2025
BUY
$99.75 - $151.89 $1.14 Million - $1.73 Million
11,408 Added 2.0%
581,505 $88.2 Million
Q1 2025

Apr 15, 2025
BUY
$150.52 - $190.14 $81.1 Million - $102 Million
538,792 Added 1721.11%
570,097 $85.8 Million
Q4 2024

Jan 14, 2025
SELL
$178.58 - $220.69 $3.17 Million - $3.91 Million
-17,725 Reduced 36.15%
31,305 $5.78 Million
Q3 2024

Oct 23, 2024
BUY
$187.96 - $245.29 $5.57 Million - $7.27 Million
29,621 Added 152.61%
49,030 $9.66 Million
Q2 2024

Jul 18, 2024
SELL
$206.39 - $268.73 $3.89 Million - $5.06 Million
-18,847 Reduced 49.27%
19,409 $4.01 Million
Q1 2024

Apr 24, 2024
BUY
$203.52 - $273.43 $2.6 Million - $3.49 Million
12,769 Added 50.1%
38,256 $10.4 Million
Q4 2023

Jan 17, 2024
SELL
$164.52 - $238.84 $921,970 - $1.34 Million
-5,604 Reduced 18.02%
25,487 $6.03 Million
Q3 2023

Nov 06, 2023
BUY
$194.44 - $217.61 $6.05 Million - $6.77 Million
31,091 New
31,091 $6.09 Million
Q1 2023

Apr 18, 2023
SELL
$191.89 - $259.92 $63,899 - $86,553
-333 Reduced 0.94%
35,017 $7.07 Million
Q4 2022

Jan 12, 2023
SELL
$197.11 - $250.07 $4.97 Million - $6.3 Million
-25,205 Reduced 41.62%
35,350 $7.7 Million
Q3 2022

Oct 27, 2022
BUY
$182.44 - $250.54 $3.39 Million - $4.65 Million
18,561 Added 44.2%
60,555 $11.9 Million
Q2 2022

Jul 27, 2022
BUY
$204.13 - $302.4 $6.97 Million - $10.3 Million
34,153 Added 435.57%
41,994 $8.99 Million
Q1 2022

Apr 25, 2022
SELL
$255.51 - $362.11 $3.21 Million - $4.55 Million
-12,553 Reduced 61.55%
7,841 $2.23 Million
Q4 2021

Feb 01, 2022
SELL
$351.38 - $448.68 $1.47 Million - $1.88 Million
-4,197 Reduced 17.07%
20,394 $7.68 Million
Q3 2021

Oct 19, 2021
SELL
$372.64 - $458.3 $7.33 Million - $9.01 Million
-19,669 Reduced 44.44%
24,591 $10.1 Million
Q2 2021

Jul 15, 2021
SELL
$294.17 - $371.65 $13.1 Million - $16.6 Million
-44,578 Reduced 50.18%
44,260 $16.4 Million
Q1 2021

Apr 26, 2021
BUY
$249.67 - $299.48 $12.8 Million - $15.3 Million
51,144 Added 135.68%
88,838 $25.7 Million
Q4 2020

Feb 01, 2021
SELL
$222.0 - $252.62 $1.17 Million - $1.34 Million
-5,290 Reduced 12.31%
37,694 $9.42 Million
Q3 2020

Oct 07, 2020
BUY
$175.56 - $226.45 $7.55 Million - $9.73 Million
42,984 New
42,984 $9.73 Million
Q3 2019

Oct 16, 2019
SELL
$125.07 - $143.67 $3.02 Million - $3.47 Million
-24,149 Closed
0 $0
Q2 2019

Aug 12, 2019
SELL
$123.4 - $148.55 $38.4 Million - $46.3 Million
-311,470 Reduced 92.8%
24,149 $3.43 Million
Q1 2019

Apr 26, 2019
BUY
$104.82 - $146.73 $27.6 Million - $38.6 Million
262,907 Added 361.57%
335,619 $48.7 Million
Q4 2018

Jan 23, 2019
SELL
$105.09 - $137.23 $34 Million - $44.4 Million
-323,739 Reduced 81.66%
72,712 $8.23 Million
Q3 2018

Oct 29, 2018
BUY
$112.11 - $134.54 $15.1 Million - $18.1 Million
134,594 Added 51.4%
396,451 $53.3 Million
Q2 2018

Jul 17, 2018
BUY
$102.37 - $117.25 $13.3 Million - $15.3 Million
130,325 Added 99.08%
261,857 $29.4 Million
Q1 2018

Apr 30, 2018
BUY
$98.19 - $115.2 $12.9 Million - $15.2 Million
131,532 New
131,532 $14 Million

Others Institutions Holding CRL

# of Institutions
632
Shares Held
52.8M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.11B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email